Health Affairs April 3, 2019
This week is expected to be Dr. Scott Gottlieb’s last as Commissioner of the U.S. Food and Drug Administration (FDA). During his nearly two years in the position, Commissioner Gottlieb has confronted a range of public health challenges, including the opioid epidemic, an increase in teen nicotine abuse, and natural disasters (as this Blog has already considered). He has been the rare administration official to earn praise from commentators on both sides of the aisle for his public health-centered approach and his focus not only on the agency’s consumer protection mission but also on the science behind many of these issues.
This post focuses instead on Commissioner Gottlieb’s efforts to advance policy in a number of areas relating to prescription...
Today's Sponsors
Today's Sponsor